Compositions and methods for treating autism
US11633372B2 · kind B2 · utility
1Cited by
23References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2020 |
| Grant date | Apr 25, 2023 |
| Priority date | — |
| Expiry date | Mar 7, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods of treating autism. Specifically, the invention relates to treating the core symptoms of autism by administering α-methyl-DL-tyrosine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.